OAOlusola Peter Aduloju

Olusola Peter Aduloju

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olusola Peter Aduloju has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Predictors of Primary Postpartum Haemorrhage in aTertiary Teaching Hospital in Ekiti State, Nigeria: A Facility-Based Analytical Study

    by Gbenga Damilola Akinlua, Omolola Ajayi Alao, Olaogun Oluwole Dominic, Olufunke Temiloluwa Oso, Olusola Peter Aduloju, Temitope Omoladun Okunola, Richard Akindele Akinyoade, Oluwayomi Samson Gbenga

    • 30 April 2026
      • Vol. 30  (1) , 72-80
    Open Access

    Randomised Controlled Trial of Elective Induction of Labour at 40 and 41 Weeks to Prevent Prolonged Pregnancy.

    by Oluwadare Martins Ipinnimo, Olusola Peter Aduloju, Pius Idowu Ade-Ojo, Tope Michael Ipinnimo, Adeyemi Sunday Adefisan, Oluseyi Igbekele Ipinnimo, Babatunde Ajayi Olofinbiyi, Oluwamuyiwa Temitope Fagbohun, Benedict Tolulope Adeyanju, Adewale Temitope Adeyiolu

    There have been discussions as to the time of elective induction of labour to curb the continuation of pregnancy that might endanger the lives of both the mother and child. This research was conducted to assess foetal and maternal consequences of planned delivery at 40 and 41weeks in women with low-risk singleton pregnancy. A randomised controlled trial with equal allocation of participants (96 pregnant women in each arm) into 40weeks and 41weeks. Participants were randomised at the antenatal clinic at 39 weeks for induction of labour. The main outcome was the caesarean section rate. Secondary outcomes were maternal (genital tract laceration rate) and foetal (rates of meconium staining of amniotic fluid, SCBU admission, perinatal mortality, birth trauma, birth weight, and neonatal APGAR score at 1 and 5 minutes). Student t-test and chi-square test were used for inter-group comparison. Incidence of caesarean delivery (26.6% vs. 21.3%; p=0.406), and genital laceration (2.1% vs. 5.6%; p=0.268) did not differ between groups. Significantly higher birth weight was noted among women induced at 41weeks (3.41 ± 0.37kg) than 40weeks (3.28 ± 0.46kg) (p=0.043). Also, there was significant variation in meconium staining of amniotic fluid between 40weeks (11.7%) and 41weeks (25.8%) (p=0.014). Other foetal outcomes showed no significant difference. Inducing labour at 40weeks is safe for low-risk women as it does not significantly increase the cesarean delivery rate and adverse perinatal outcomes. Therefore, elective induction of labour at 40weeks should be recommended and introduced into obstetric practice without the fear of adverse outcomes.

  • Open Access

    Outcomes of Induction of Labor at a Cottage Hospital in the Nigerian Niger Delta Region

    by Olusola P. Aduloju, Akinwunmi Fajola, Stevens D. Tuboteme, Millicent I. Onyebuchi

    INTRODUCTION: Induction of labor (IOL) remains one of the commonly performed obstetric interventions worldwide when its benefits outweigh the risks. Several factors have been shown to be associated with successful outcome of IOL (achieving vaginal delivery). This study evaluated the outcomes of IOL and the determinants of successful outcome in Obio Cottage Hospital (OCH), Port-Harcourt. METHODS: It was a retrospective analysis of all pregnant women who had IOL in the Maternity unit of OCH between 1st January 2023 and 31st December, 2023. Data were analyzed using SPSS and logistic regression done for determinants of successful IOL. RESULTS: The prevalence of IOL was 17.2% of all deliveries while 87.5% of the parturient had vaginal delivery. Postdatism and dystocia were the commonest indication for IOL and caesarean section after failed IOL respectively. Estimated fetal weight of 2.5-3.9kg [AOR = 3.41, 95% CI (1.09- 5.32)], cervical ripening with combined Foley’s catheter and misoprostol [AOR = 3.76, 95% CI (1.23-7.36)] and misoprostol only [AOR = 1.68, 95% CI (1.12-5.72)]; and birth weight of 2.5-3.9kg [AOR = 4.35; 95% CI (1.82-6.01)] were the determinants of vaginal delivery among the parturient. CONCLUSION: In carefully selected parturient and with the use of appropriate method of cervical ripening, IOL is safe with high successful vaginal delivery rate and good maternal and perinatal outcomes.

  • Open Access

    Sero-Epidemiology of Transfusion Transmissible Hepatitis B, C and E among Blood Donors in Ekiti, Southwestern Nigeria: A Cross-sectional Study

    by K. A. Fasakin, M. A. Muhibi, A. A. Ibijola, O. D. Ajayi, M. I. Onyema, Y. Obazee, A. A. Adeniyi, W. A. Ajetunmobi, I. O. Adebara, A. Adebayo, et al.

    Background: Transfusion transmissible hepatitis (TTH) is a global health problem and the incriminating agents such as hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis E virus (HEV) continue to pose serious threats to blood safety. The aim of this study was to determine the seroprevalence of HBV, HCV and HEV and relate the outcomes with blood donation type, age and gender and confirm any significant associations. Materials and Methods: In this cross-sectional study, Hepatitis B surface antigen (HBsAg) and antibody to HCV were determined with Diaspot and Lab Acon immunochromatographic ELISA-based test devices. Antibodies to HEV were first determined with Biopanda lateral flow device followed by ELISA assay for sero-reactive HEV immunoglobulins M and immunoglobulin G (IgM and IgG) antibodies. Results: A total of 370 prospective blood donors between 18 and 55 years old (mean 31.2 ± 7.6 years) who presented for blood donation at FETHI Blood Bank were screened. Overall male: female ratio was 7:1. Cummulative hepatitis seroprevalence of 8.1% was found mainly among the replacement blood donors (RBD) and consist of 4.3%, 1.6%, 1.1%, 0.8% and 0.3% serologic evidence of HBsAg, anti-HCV, HEV IgM, both HEV IgM & HEV IgG, and HEV IgG antibodies. Blood donors aged 18 – 45 years were most affected with evident significant association between the age group of donors and TTH seroprevalence. Cummulative hepatitis seroprevalence was 0% among voluntary blood donors, and 9.1% and 0.3% among the male and female RBD respectively. There was significant association between the pathogens and RBD, though the association with male gender was clinically but not statistically significant. Conclusion: The high transfusion transmissible hepatitis seroprevalence among RBD called for promoting voluntary donations. Comparable prevalence of HEV antibodies with that of HCV called for its inclusion in the TTIs screening algorithm to ascertain optimal blood safety in Nigeria.

  • Preliminary report of sexual assaults at Ekiti Sexual Assault Referral Centre, Ado-Ekiti, Southwest, Nigeria (Moremi Clinic)

    by Temitope O Okunola, Babatunde A Olofinbiyi, Olusola P Aduloju, Tolulope Aduloju, Abiodun Obadeji, Adedotun S Ajiboye, Rita Ilevbare, Olabisi Adeleye-Fayemi

    There has been a surge in the incidence and severity of sexual assaults globally with the insurgence of COVID-19 owing to lockdown restrictions. Ekiti Sexual Assault Referral Centre, Ado-Ekiti also known as Moremi Clinic was established in June 2020 as a multisectoral response centre to this surge. Seventy-four survivors accessed medical services from June 2020 to May 2021. Adolescents made up 54.1% while the median age was 14.5 years. Only seven survivors were seen within 24 h of the event and around a quarter had follow-up visits. A quarter of survivors reported repeat episodes of sexual assault. Complications documented were sexually transmitted infections (13.5%), depression (4.1%) and posttraumatic stress disorder (5.4%). There was a failure of contraception in 4.5% of survivors who had taken emergency contraceptive pills. For improvements in quality of care, strategies to ensure early presentation and encourage follow-up visits must be introduced.


  • Comparison of self-esteem and depression among fertile and infertile women in a low resource setting

    by Akinyemi A. Akintayo, Olusola P. Aduloju, Mobolaji U. Dada, Olayinka A. Abiodun-Ojo, Lateef O. Oluwole, Idowu P. Ade-Ojo

    This study aimed to explore the effect of infertility on self-esteem and depression, and to identify the sociodemographic and infertility characteristics associated with self-esteem and depression among infertile women in Ekiti State, Nigeria. Self-esteem and depression were assessed in 100 infertile women and 100 women seeking family planning (controls) using the Rosenberg Self-Esteem Scale (RSES) and Patient Health Questionnaire (PHQ-9), respectively. Infertile women had significantly lower RSES score (19.4 ± 4.5 vs. 20.7 ± 4.4, p=.038) and higher PHQ-9 score (5.1 ± 4.1 vs. 3.8 ± 3.5, p=.023) compared to controls. Among infertile women, marital status, being remarried, duration of infertility, and RSES score were associated with PHQ-9 score on simple linear regression. On multiple linear regression analysis, the RSES score had a negative association with the PHQ-9 score (β= −0.32, p<.001). In conclusion, infertile women have lower self-esteem and higher depression scores. Mental health screening and management should be an integral part of care administered to infertile women.


  • Utilization of Long-Acting Reversible Contraceptive (LARC) Methods in a tertiary hospital in southwestern Nigeria: A Mixed Methods Study

    by Olusola P. Aduloju, Akinyemi A. Akintayo, Adeyemi S. Adefisan, Tolulope Aduloju

    Background/Purpose There is an increasing trend in the utilization of long-acting reversible contraceptive (LARC) methods globally. The study assessed the utilization of LARC methods and its determinants in a tertiary hospital, southwestern Nigeria using a mixed method study. Methods A cross-sectional study of women attending the Family Planning Clinic of the tertiary hospital was conducted between November 1, 2018 and October 31, 2019 using both quantitative and qualitative methods. Quantitative data was collected using structured questionnaire while in-depth interviewer topic guide was used to obtain qualitative data from the respondents. The quantitative and qualitative data obtained from the respondents were analyzed using SPSS version 22 and open code version 3.6.2, respectively, and the determinants of utilization of LARC methods were identified using multivariate regression model. Results The current utilization rate of LARC methods was 65.6% and implants accounted for 75% of LARC used. Higher education (p = 0.035), more than 3 living children (p = 0.030), previous use of LARC (p = 0.028), good knowledge (p = 0.025) and positive attitude of the women about LARC (p = 0.026) were significant determinants of utilization among the women. Limiting size of family was the commonest reason among LARC users, while partner disapproval, fear of procedure and side effects were reasons given by non-users. Conclusions The utilization rate of LARC methods are high, and this should be sustained through improved information dissemination, education of women and involvement of male partners in reproductive health matters including family planning.


  • Open Access

    Outcome of Management of Pregnant Women with Decreased Fetal Movements in a Resource Constrained Setting in Southwest Nigeria

    by Olusola Peter Aduloju, Babatunde Ajayi Olofinbiyi, Olabisi Deji-Dada, Tolulope Aduloju

    Aims: To evaluate pregnant women with decreased fetal movements (DFM) identifying the risk factors and perinatal outcomes of such pregnancies. Study Design: A case-control study. Place and Duration of Study: Department of Obstetrics and Gynecology, Ekiti State University Teaching Hospital, Ado-Ekiti, between April 1 2017 and March 31 2018. Methodology: Women with singleton pregnancy presenting to the Department with complaint of DFM (cases) after 28 weeks of gestation were recruited and compared with women with no complaint of DFM that delivered in the facility during the study period. Sociodemographic data, obstetric characteristics. Antenatal risk factors, mode of delivery and perinatal outcomes were obtained using a semi-structured questionnaire. Data collected were analyzed with SPSS and variables were compared using student t test and chi square or Fisher exact test while p value was 0.05. The mean gestational age at presentation and delivery were significantly lower among women with DFM (31.95 ± 1.81 weeks versus 37.46 ± 2.98 weeks; P=0.001 and 35.05 ± 1.47 weeks versus 37.46 ± 2.98 weeks; P=0.001 respectively). More women with DFM significantly had preeclampsia and intrauterine growth restrictions (P=0.002), oligohydramnios (p=0.016), caesarean delivery (P=0.005) and SCBU admission (P=0.009). The mean birth weight and Apgar scores at 1 minute were significantly lower in women with DFM (2.64 ± 0.54 kg versus 3.25 ± 0.57 kg; P=0.001 and 7.13 ± 0.68 versus 7.42 ± 0.82; P=0.003 respectively). Conclusion: This study showed that women with DFM are a higher risk of operative delivery and poor perinatal outcome such birth weight and Apgar score. Maternal perception of fetal movements should form part of risk assessment during routine visits.

  • Open Access

    Randomised Controlled Trial of Sublingual and Rectal Misoprostol in the Prevention of Primary Postpartum Haemorrhage in a Resource-Limited Community

    by Jacob Olumuyiwa Awoleke, Benedict Tolulope Adeyanju, Adebayo Adeniyi, Olusola Peter Aduloju, Babatunde Ajayi Olofinbiyi

    Background/Purpose Misoprostol is beneficial in preventing postpartum haemorrhage (PPH). However, there is no consensus yet as to which route will give the balance of efficacy, safety and patient preference, especially at the recommended dose of 600 mcg. This study compared the efficacy and adverse effects of rectal and sublingual misoprostol for the prevention of PPH. Methods In a prospective fashion, consenting eligible parturients were randomised into two groups to receive either 600 mcg of misoprostol rectally or sublingually after vaginal delivery. All study participants were followed up till 24 h postpartum. Primary outcomes were blood loss of 500 ml or greater and at least 10% change in peripartum haematocrit levels. Results Seven (6.7%) and 16 (15.7%) of the sublingual and rectal routes, respectively, had PPH. However, the odds of having PPH after rectal misoprostol were at least twice the odds after the sublingual route (p = 0.041). Also, the mean blood loss after the first, fourth and 24th hour postpartum were significantly higher after rectal administration. Although significantly more patients had shivering and pyrexia after sublingual misoprostol, it was acceptable to more participants than the rectal route. Conclusion At the recommended dose, sublingually administered misoprostol (‘the sweet of life’) is associated with a lower incidence of PPH than the rectal route. Despite its higher incidence of shivering and pyrexia, it was accepted by more women than rectally administered misoprostol. ClinicalTrials.gov identifier PACTR201911500348367.


  • Oral misoprostol for induction of labor at term: a randomized controlled trial of hourly titrated and 2 hourly static oral misoprostol solution

    by Olusola Peter Aduloju, Oluwadare Martins Ipinnimo, Tolulope Aduloju

    Background: Misoprostol has been shown to be effective in induction of labour (IOL) with different dosages and routes of administration. Objectives: This study compared the efficacy and safety of hourly titrated and 2-hourly static low dose oral misoprostol for IOL in Ekiti State University Teaching Hospital, Ado-Ekiti. Methods: One hundred fifty women with singleton pregnancy at term admitted for IOL were randomized into the two groups. Oxytocin augmentation was done as necessary. The primary outcome is rate of vaginal delivery within 24 hours. Data was analyzed using SPSS. Results: Vaginal delivery was achieved within 24 hours in 40 (67.8%) women who received hourly titrated-doses oral misoprostol and 42 (70.0%) women who received 2-hourly static-dose of oral misoprostol, p > 0.05. The rate of vaginal delivery, oxytocin augmentation, induction delivery time and cesarean section rate were similar in both groups, p > 0.05. Occurrence of uterine hyperactivity did not differ significantly among the women (p > 0.05) and no cases of uterine rupture were recorded. There were no adverse neonatal outcomes. Conclusions: The hourly titrated oral misoprostol is as effective and safe as the 2-hourly static oral misoprostol for IOL. Both can be utilized in IOL without the fear of adverse outcomes.